Source: PR Newswire

Press Release: PreciseDx : PreciseDx Announces Poster Presentation at The 2024 American Society of Clinical Oncology Annual Meeting

/PRNewswire/ -- PreciseDx®, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for morphology-driven disease analysis, today...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Wayne Brinster's photo - President & CEO of PreciseDx

President & CEO

Wayne Brinster

CEO Approval Rating

90/100

Read more